WARNING: This product contains nicotine. Nicotine is an addictive chemical.
Air 2, LLC Patents
Air 2, LLC has created a nano-based, water-soluble technology, capable of delivering a proprietary, micelle (purified 99.9% pure) Nicotine formulas.
The company has been issued three U.S. patents U.S. 12,016,401, 12,108,809 and 12,262,756 with a PCT application PCT/US24/29212 filed 05/14/2024.
The company’s proprietary, aerosol manufacturing processes observe EPA and FDA regulatory guidelines. All ingredients are FDA GRAS compliant by the Natural and Non-Prescription Products Group and are 3rd party tested and produced in cGMP compliant facilities that employ pharmaceutical grade equipment, components, and processes.
AEROSOL PRESSURIZED INHALATION DELIVERY DEVICE AND METHODS FOR MANUFACTURE AND USE OF THE SAME
U.S. Patent. No.: 12,016,401
Filed: April 14, 2023
AEROSOL PRESSURIZED DELIVERY DEVICE AND METHODS FOR MANUFACTURING AND USE OF THE SAME
U.S. Patent. No.: 12,108,809
Filed: April 18, 2024
METHODS FOR DELIVERING A MICELLIZED LIQUID FORMULA TO AN INDIVIDUAL
U.S. Patent No.: 12,262,756
Filed: September 25, 2024
Air 2, LLC Patents Summary
AEROSOL PRESSURIZED INHALATION DELIVERY DEVICE AND METHODS FOR MANUFACTURING AND USE OF THE SAME
U.S. Utility Patent No.: 12,016,401
Aspects of the present issued patent relate generally to a device for delivering a micellized liquid Nicotine formula and related systems and methods, and more particularly a pressurized inhalation delivery device that eliminates a cartridge or reservoir or pod, the heating element and power source or battery.
AEROSOL PRESSURIZED DELIVERY DEVICE AND METHODS FOR MANUFACTURING AND USE OF THE SAME
U.S. Utility Patent No.: 12,108,809
The issued patent improves and enhances the delivery of a micellized liquid Nicotine formula by use of a pressurized aerosolized sublingual delivery device which includes one or more replaceable or reusable components, including but not limited to a canister, actuator, metered valve, and child resistant receptacle.
METHODS FOR DELIVERING A MICELLIZED LIQUID FORMULA TO AN INDIVIDUAL
U.S. Utility Patent No.: 12,262,756
The issued patent relates to an aerosol pressurized inhalation delivery device having an actuator, continuous or metered valve, receptacle housing and metal canister allowing a micellized liquid Nicotine formula to be expelled through the actuator discharge nozzle and inhaled directly into the lungs or delivered to the individual sublingually.
PRESSURIZED SUBLINGUAL DELIVERY DEVICE AND METHODS FOR MANUFACTURE AND USE OF THE SAME
Patent Cooperation Treaty (PCT) Application No. PCT/US24/2912
The present disclosure relates to an encapsulated, pressurized, sublingual NanoMist Vapor delivery device, which may deliver a formula, including a micellized liquid nicotine formula. The device comprises a protective receptacle or housing, which preferably houses at least one canister, and a receptacle cap. The device may also comprise a custom actuator in communication with a metered valve for delivering a precise, known volume of at least one micellized liquid nicotine formula sublingually to the user.
Contact:
Address:
8100 S. Akron Street
Suite No. 316
Centennial, Colorado 80112 USA
*The products and statements provided herein have not been evaluated by the Food & Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.
Copyright ©2025 VAPOR™ is a trademark of Air 2, LLC a Colorado Company All Rights Reserved